Oliver Crook — Chief European Correspondent, Bloomberg (3 trade ideas)

← All Speakers
Date Ticker Direction Thesis Source
Feb 18, 2026
AZN
LONG 13F filings reveal Berkshire Hathaway has been "buying into AstraZeneca" while simultaneously slashing stakes in major US tech and financials. When the "Oracle of Omaha" rotates out of cyclical consumer/tech names into defensive healthcare, it signals a shift toward safety and undervaluation in the pharma sector. LONG AZN as a copy-trade of Berkshire's defensive rotation. Drug pipeline failures or regulatory pricing pressure in the pharmaceutical sector. Bloomberg Markets
US-Iran Talks 'Progress' & Lagarde Reported t...
Feb 18, 2026 AVOID Berkshire Hathaway reduced its stake in Amazon by more than 745% (likely meant shares or basis points, but the sentiment is heavy selling), and also trimmed allocations in Apple and Bank of America. Institutional capitulation by a major long-term holder suggests these assets may be fully valued or facing headwinds that retail investors haven't priced in yet. AVOID or TRIM exposure to align with smart money outflows. These companies continue to compound earnings despite Buffett's exit, forcing a chase. Bloomberg Markets
US-Iran Talks 'Progress' & Lagarde Reported t...
Feb 16, 2026 LONG Allies have pledged $35 billion in new military aid to Ukraine, specifically targeting "Air Defenses" and Patriot systems. RTX (Raytheon) manufactures the Patriot system. A $35B injection focused on air defense directly translates to order book growth for the prime contractors manufacturing these interceptors and batteries. LONG Defense primes, specifically those exposed to air defense systems. Geopolitical de-escalation or funding delays. Bloomberg Markets
AI 'Scare Trade' Takes Hold; Talabat FY Earni...